Publication Name	World Journal of Diabetes
Manuscript ID	22334
Country	Mexico

Received	2015-08-27 09:47
Peer-Review Started	2015-08-30 18:08
To Make the First Decision	2015-09-28 12:08
Return for Revision	2015-10-09 15:49
Revised	2015-10-23 08:11
Second Decision	2016-01-27 13:57
Accepted by Journal Editor-in-Chief	2016-01-29 07:42
Accepted by Executive Editor-in-Chief	2016-02-16 09:47
Articles in Press	2016-02-16 09:47
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-03-31 12:23
Publish the Manuscript Online	2016-04-06 16:52

ISSN	1948-9358 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Nutrition & Dietetics
Manuscript Type	Review
Article Title	Novel nutraceutic therapies for the treatment of metabolic syndrome
Manuscript Source	Invited Manuscript
All Author List	Esperanza Martínez-Abundis, Miriam Mendez-del Villar, Karina G Pérez-Rubio, Laura Y Zuñiga, Marisol Cortez-Navarrete, Alejandra Ramírez-Rodriguez and Manuel González-Ortiz
Funding Agency and Grant Number
Corresponding Author	Manuel González-Ortiz, MD, MSc, PhD, Institute of Experimental and Clinical Therapeutics, Department of Physiology, Health Sciences University Center, University of Guadalajara, Montes Urales 1409, Colonia Independencia, Guadalajara 44340, Jalisco, Mexico. uiec@prodigy.net.mx
Key Words	Nutraceutics; Metabolic syndrome; Ber­berine; Bitter melon; Gymnema silvestre; Irvingia gabonensis; Resveratrol; Ursolic acid
Core Tip	Metabolic syndrome (MetS) is a cluster of endocrine problems including obesity, dysglycemia, dyslipidemia, and hypertension. Unfortunately, there is no unique treatment to control it. Nutraceutic therapies such as berberine, bitter melon, Gymnema sylvestre, Irvingia gabonensis, resveratrol and ursolic acid have demonstrated some improvement in anthropometric parameters and cardiometabolic risk factors and could be considered as treatment for patients with MetS. This review attempts to demonstrate the beneficial effects and limitations of some of these novel nutraceutic therapies.
Publish Date	2016-04-06 16:52
Citation	Martínez-Abundis E, Méndez-del Villar M, Pérez-Rubio KG, Zuñiga LY, Cortez-Navarrete M, Ramírez-Rodriguez A, González-Ortiz M. Novel nutraceutic therapies for the treatment of metabolic syndrome. World J Diabetes 2016; 7(7): 142-152
URL	http://www.wjgnet.com/1948-9358/full/v7/i7/142.htm
DOI	http://dx.doi.org/10.4239/wjd.v7.i7.142

Full Article (PDF)	WJD-7-142.pdf
Full Article (Word)	WJD-7-142.doc
Manuscript File	22334-Review.docx
Answering Reviewers	22334-Answering reviewers.pdf
Audio Core Tip	22334-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	22334-Conflict-of-interest statement.pdf
Copyright License Agreement	22334-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	22334-Language certificate.pdf
Peer-review Report	22334-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	22334-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	22334-Scientific misconduct check.pdf
Scientific Editor Work List	22334-Scientific editor work list.pdf